Rifaximin, a Peculiar Rifamycin Derivative: Established and Potential Clinical Use Outside the Gastrointestinal Tract

Publisher： Karger

E-ISSN： 1421-9794|51|1|122-130

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.1, 2005-04, pp. : 122-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 36-66

Karger

Access to resources Recommend Favorite

Established Clinical Use of Octreotide and Lanreotide in Oncology

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-03 ,pp. : 40-53

Karger

Access to resources Recommend Favorite

Metaphylogenomic and Potential Functionality of the Limpet Patella pellucida’s Gastrointestinal Tract Microbiome

By Dudek Magda   Adams Jessica   Swain Martin   Hegarty Matthew   Huws Sharon   Gallagher Joe  

International Journal of Molecular Sciences, Vol. 15, Iss. 10, 2014-10 ,pp. : 18819-18839

MDPI

Access to resources Recommend Favorite

Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract

By Vicentini Caterina   Fassan Matteo   D’Angelo Edoardo   Corbo Vincenzo   Silvestris Nicola   Nuovo Gerard J.   Scarpa Aldo  

Molecules, Vol. 19, Iss. 2, 2014-02 ,pp. : 2458-2468

MDPI

Access to resources Recommend Favorite

Clinical Use of the Antiseptic Polihexanide for Genital Tract Infections

By  

Skin Pharmacology and Physiology, Vol. 25, Iss. 6, 2012-08 ,pp. : 298-304

Karger

Access to resources Recommend Favorite